Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients.

Oliva Mejía-Rodríguez(Mexican Social Security Institute), José Ramón Paniagua-Sierra, Francisco Belio-Caro(Mexican Social Security Institute), Helios Eduardo Vega-Gómez, Cleto Álvarez-Aguilar, Juan M Vargas-Espinosa

PubMed

January 1, 2005

Cited by 13

Related Papers

Academic student satisfaction and perceived performance in the e-learning environment during the COVID-19 pandemic: Evidence across ten countries

|PLoS ONE|2021|186

Higher education students’ achievement emotions and their antecedents in e-learning amid COVID-19 pandemic: A multi-country survey

|Learning and Instruction|2022|60

Cardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease

|BioMed Research International|2013|25

Inflamación en hemodiálisis y su correlación con los índices neutrófilos/linfocitos y plaquetas/linfocitos

|Nefrología|2017|15

Prevalence of malnutrition-inflammation complex syndrome and its correlation with thyroid hormones in chronic haemodialysis patients

|Nefrología (English Edition)|2017|15